Viking Therapeutics Inc. logo

Viking Therapeutics Inc.

VKTX | NASDAQ
Chart Builder DCF Calculator
$30.11
+$1.12 (+3.86%)
At close: Sep 21, 2026, 4:00 PM ET
$32.06
+$1.95 (+6.48%)
Pre-market: Sep 22, 2026, 6:26 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
165.81M 26.68M 55.52M 36.63M 26.37M 29.12M
Short-Term Investments
539.93M 875.94M 306.56M 118.85M 175.73M 219.27M
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
46K 102K 139K 71K 109K 78K
Receivables
n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
1.81M 1.13M 2.52M 8.14M 7.81M 7.28M
Total Current Assets
715.6M 907.22M 367.23M 167.04M 210.53M 256.1M
Property-Plant & Equipment
85K 1M 1.13M 1.42M 25K 321K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
131K 1.11M 1.27M 1.49M 134K 399K
Total Assets
715.73M 908.32M 368.49M 168.53M 210.66M 256.5M
Account Payables
53.25M 9.81M 7.51M 8.53M 1.44M 3.99M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a n/a n/a
Total Current Liabilities
76.67M 27.41M 19.14M 21.95M 8.78M 12.13M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a 630K 936K 1.26M n/a 29K
Total Liabilities
76.67M 28.04M 20.07M 23.21M 8.78M 12.16M
Total Debt
137K 1.12M 1.26M 1.56M 29K 359K
Book Value
639.06M 880.28M 348.42M 145.32M 201.88M 244.34M
Book Value Per Share
5.67 8.07 3.69 1.89 2.62 3.37
Common Stock
1K 1K 1K 1K 1K 1K
Retained Earnings
-847.55M -487.91M -377.94M -292.05M -223.18M -168.19M
Comprehensive Income
378K -788K -389K -1.1M -549K -54K
Shareholders Equity
639.06M 880.28M 348.42M 145.32M 201.88M 244.34M
Total Investments
539.93M 875.94M 306.56M 118.85M 175.73M 219.27M

© 2026 bestshares.com. All rights reserved.